Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Zo World is a global travel ecosystem powered by local friends called Zo Community.
Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Gayam Motor Works designs, manufactures, and sells most advanced electric bikes and smart autos.
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Bioneb offers direct to consumer genetic testing companies in India.
DWC 3.0 is a holding company that provides investment services.
The Global Emerging Markets Group has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
The Global Emerging Markets Group's top investment sectors include Biotechnology, Biopharma, Adventure Travel, Communities, Travel. The firm invests across 15 different industry categories.
Among tracked funding rounds, Bioneb received $286.7M in a Private Equity round. The Global Emerging Markets Group's total known invested capital is $5.0B.
The Global Emerging Markets Group's average investment size is $77.8M across its portfolio of 79 companies.
Recent The Global Emerging Markets Group portfolio additions include Zo World, Captura Biopharma, Cytocom, Gayam Motor Works, Novaremed AG. These companies were founded in 2020 or later.